gdc

Endometrial Cancer

ECANA: Endometrial Cancer Action Network for African-Americans: An interview with Jacqueline Mbayo, Adrienne Moore, and Margie Wilson about the work of the ECANA community
Interview with the AdvocatesEndometrial Cancer
From their “Survivors’ Sanctuary” to their collaboration with academic researchers, the Endometrial Cancer Action Network for African-Americans (ECANA) is a national organization dedicated to improving the lives of Black women with endometrial cancer.
Beyond Chemotherapy: Immunotherapy Offers a New Treatment Option for Women with Endometrial Cancer
ImmunotherapyEndometrial Cancer
Dr. Binder, of the University of California, San Diego, describes immunotherapy as the most recent advance in the treatment of endometrial cancer.
Fertility After a Cancer Diagnosis
SurvivorshipFertility PreservationEndometrial Cancer
For young adults facing a cancer diagnosis, consideration of fertility preservation is an important component of the treatment plan.
Treatment Options for Endometrial Cancer
Endometrial Cancer
There are more effective treatment options available to you today than ever before. Here, Ms. Atkinson outlines treatments by stage.
Endometrial Cancer 101: The Terms You Need to Know
Endometrial Cancer
A diagnosis of endometrial cancer comes with a new vocabulary. These are the terms you need to know.
Drugs for Endometrial (Uterine) Cancer
Endometrial Cancer
Find financial assistance programs available for endometrial (uterine) cancer drugs.
Jemperli First Immunotherapy FDA Approved for Endometrial Cancer with dMMR Biomarker
Endometrial CancerFDA Approvals, News & UpdatesImmunotherapy
In April 2021, the FDA approved Jemperli (dostarlimab-gxly) for patients with recurrent or advanced endometrial cancer and the biomarker mismatch repair-deficient. This is the first immunotherapy approved for patients with this type of cancer.

Results 1 - 9 of 9

Subscribe to CONQUER: the patient voice

Receive timely cancer news & updates, patient stories, and more.


Country
Race or Ethnicity
Gender
Profession or Role
Primary Interest
Other Interests